Navigation Links
FDA Approves Vaccines for the 2011-2012 Influenza Season
Date:7/18/2011

SILVER SPRING, Md., July 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce and distribute influenza vaccine for the United States.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Vaccination remains the cornerstone of preventing influenza, a contagious respiratory disease caused by influenza virus strains. The vaccine formulation protects against the three virus strains that surveillance indicates will be most common during the upcoming season and includes the same virus strains used for the 2010-2011 influenza season.

Between 5 percent and 20 percent of the U.S. population develops influenza each year, leading to more than 200,000 hospitalizations from related complications, according to the U.S. Centers for Disease Control and Prevention (CDC). Influenza-related deaths vary yearly, ranging from a low of about 3,000 to a high of 49,000 people.  

"Vaccines to prevent seasonal influenza have a long and successful track record of safety and effectiveness in the United States," said Karen Midthun, M.D., director of FDA's Center for Biologics Evaluation and Research. "It is important to get vaccinated every year, even if the strains in the vaccine do not change, because the protection received the previous year will diminish over time and may be too low to provide protection into the next year."

In addition to the important role that health care providers play in recommending influenza vaccination for their patients, influenza vaccination of health care personnel is also important to protect themselves, their patients, their family, and the community from influenza. The FDA urges health care organizations to encourage their members to follow CDC's Advisory Committe
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People
2. FDA Approves Arcapta Neohaler to Treat Chronic Obstructive Pulmonary Disease
3. FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
4. FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
5. FDA Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections
6. FDA Approves Nulojix for Kidney Transplant Patients
7. FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
8. FDA Approves First Ceramic-on-Metal Total Hip Replacement System
9. FDA Approves Redesigned Labels for Some Merck Drugs
10. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
11. FDA Approves Marketing of RMS Subcutaneous Needle Sets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014  Royal Philips (NYSE: PHG, ... company,s latest innovation designed to empower seniors to live ... the company,s leading U.S.-based call center, the mobile app ... recent survey by Philips and the Global ... School of Business, 96 percent of senior respondents ...
(Date:8/26/2014)... --   Practice Fusion , the country,s largest cloud-based ... addition to its executive team of Tom Langan ... Joe Priest as the company,s vice president of ... hire of Robert Park as its chief financial officer, ... bench. With the addition of two industry veterans, these ...
(Date:8/26/2014)... DIEGO , Aug. 26, 2014   Tocagen ... has been named vice president, clinical development, and ... clinical operations. "As we advance Toca ... are expanding our clinical team with individuals who have ... commercialization activities," said Jamey Skillings , M.D., Chief ...
Breaking Medicine Technology:Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 2Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 3Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires 2Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires 3Tocagen Expands Clinical Development Team; 2Tocagen Expands Clinical Development Team; 3
... , , THOUSAND OAKS, ... today announced positive top-line results from a Phase 3 trial ... as a second-line treatment in 1,186 patients with metastatic colorectal ... overall survival. , , Vectibix significantly ...
... , , , ... a world-leading developer and marketer of innovative medical technologies for ... data demonstrating positive clinical results achieved with the Engenex((R)) Advanced ... , The Engenex((R)) NPWT System, utilizing low ...
Cached Medicine Technology:Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 2Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 3Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 4Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 5Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 6Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 7Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 8New Data Supports ConvaTec Negative Pressure Wound Therapy 2New Data Supports ConvaTec Negative Pressure Wound Therapy 3
(Date:8/27/2014)... PCOS (Polycystic Ovarian Syndrome) affects an ... risk for a number of health disorders and medical ... understood even within the medical community. Many women are ... and excess body fat around the waist area (truncal ... are caused by PCOS. , Awareness is the first ...
(Date:8/27/2014)... 2014 iHire was recognized for ... “Most Creative Workplace” in Frederick, a new category ... Work Awards. , Held at the Delaplaine Visual ... joint partnership between the Frederick County Workforce Services, ... County Business Development and Retention, and Frederick County ...
(Date:8/26/2014)... August 27, 2014 Hearing aids ... be hard for plan holders to determine what their hearing ... participating in several additional health plans and has published benefit ... assistance page . , The following is a list ... a participating provider: , NYSHIP/ NYS Empire Plan - Hearing ...
(Date:8/26/2014)... AlignLife of Wauwatosa held its second annual Thanksgiving in July ... collect at least 300lbs of food for our local Hunger ... not only reach this goal, but also had us way ... of food during their month-long food drive. , "We definitely ... Sam. "We look forward to collecting well over the 600lb ...
(Date:8/26/2014)... 27, 2014 A Forever Recovery, ... their annual alumni picnic on Saturday, August 17, with ... Snake” Roberts. , Each year, graduates from all over ... while several share their own story during the open ... are still in the program. , Roberts, who was ...
Breaking Medicine News(10 mins):Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:iHire Named Most Creative Workplace in Frederick, MD 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:AlignLife Wauwatosa Thanksgiving in July Yields over 500 lbs of Food 2Health News:A Forever Recovery Wraps Up Successful Annual Alumni Picnic Featuring Former Pro Wrestler Jake “The Snake” Roberts 2Health News:A Forever Recovery Wraps Up Successful Annual Alumni Picnic Featuring Former Pro Wrestler Jake “The Snake” Roberts 3
... Internationally renowned scientist Dr. Huda Zoghbi, a pioneer in ... disorders, will receive the 2009 Vilcek Prize in biomedical ... 2006," said Dr. Jan Vilcek, President and Cofounder of ... announce the expansion of our awards program with the ...
... Help Companies Design, Prototype and Deploy Medical Devices Faster ... Instruments (Nasdaq: NATI ) today announced it ... development by offering software and training grants in ... device industry continues to thrive. A recent study of ...
... to Sponsor the Congenital Heart Futures Act - ... Disease Registry, Congenital Heart Defect Research and EducationCHICAGO, ... - the country,s leading organization solely dedicated to ... organizations participating in National Congenital Heart Lobby Day ...
... 9 ARKRAY USA, Inc., the 5th largest,Blood Glucose ... U.S. Food and Drug Administration for the GLUCOCARD(R) 01-mini ... new system requires no coding, displays results in 7 ... was developed to use the same,affordable test strips as ...
... Feb. 9 Global multiservice public relations,agency ... live panel discussion,titled "Healthcare Communications in the ... Regulated Environment." The presentation will take place ... the company,s Washington, D.C., office and be,available ...
... Denver Announces New Hospitalist PartnerTACOMA, Wash., Feb. 9 ... Hospital) has selected Sound Inpatient Physicians(TM) (Sound) to ... care at its Denver facility."Selecting an experienced hospitalist ... promise to elevate patient care to ambitious new ...
Cached Medicine News:Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 2Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 3Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 4Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 5Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 6Health News:National Instruments to Further Medical Device Development With Grants in 2009 2Health News:National Instruments to Further Medical Device Development With Grants in 2009 3Health News:National Instruments to Further Medical Device Development With Grants in 2009 4Health News:The Children's Heart Foundation to Support National Congenital Heart Coalition (NCHC) on Capitol Hill by Participating in National Congenital Heart Lobby Day on February 10 2Health News:The Children's Heart Foundation to Support National Congenital Heart Coalition (NCHC) on Capitol Hill by Participating in National Congenital Heart Lobby Day on February 10 3Health News:ARKRAY USA Receives FDA Clearance on GLUCOCARD(R) 01-mini Blood Glucose Monitoring System 2Health News:Healthcare Online Regulations Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2Health News:Sound Inpatient Physicians Expands to Long-Term Acute Care Facilities 2
... The UNFOLDER Silver-T is a refinement of ... to use. Offering proven ease of implantation, The ... lens 2-1/2 times faster than The UNFOLDER Silver ... a single twist, yet The UNFOLDER Silver-T provides ...
... contains a plunger style advance, or a ... for multiple use. The injector is made ... STAAR cartridges. These injectors are sold sterile, ... This system was designed specifically for easy ...
... Laserex Ultra Q is the fundamental capsulotmy laser ... energy delivery and provides 2855% less energy in ... mJs in contemporary systems. This technology eliminates ... the risk of IOL pitting. , , ...
... The Ultrasonix ES500 system is an ... system that provides excellent clinical performance. ... software processing of the ES500 system ... penetration and every system offers a ...
Medicine Products: